Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Samantha Fraser-Bell, EURETINA 2019 – Results of the AUSSIDEX study

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 19th 2019

Samantha Fraser-Bell (University of Sydney) caught up with us to share the latest results of the AUSSIDEX study, and discuss the real-world impact on patients with DME.

Questions:
1. What are the main challenges you face when treating patients with diabetic macular oedema? (0:04)
2. Tell us about your current research in this area (0:31)
3. How can the results impact real world practice? (1:58)
4. What do you expect to be the key talking points at this year’s EURETINA meeting? (2:24)

Support: No funding was received in the production of this video.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup